-
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Risk of Developing Diabetic Retinopathy and Diabetic Macular Edema in Patients With Insulin Therapy Vs Newer Oral Hypoglycemic Agents (SGLT2i and GLP-1)
Mar 10, 2025, 14:00 PM -
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (HRQoL) Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance
Mar 10, 2025, 14:00 PM -
Importance of Virtual Access for Mental Health Services: Evidence from ESI Population
Mar 10, 2025, 14:00 PM -
Are Workforce Productivity Measures Useful for Formulary Management Decision-Making?
Mar 10, 2025, 14:00 PM -
Real-World Adherence, Healthcare Resource Utilization, And Costs Among Patients With Schizophrenia Utilizing Once-Monthly, Once-Every-Three-Months, And Once-Every-Six-Months Paliperidone Palmitate in the United States
Mar 10, 2025, 14:00 PM -
Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer
Mar 10, 2025, 14:00 PM -
Impacts of the Inflation Reduction Act on 2025 Formulary Coverage in Medicare Part D Plans
Mar 10, 2025, 14:00 PM -
A Conceptual Model of Multiple Myeloma Symptoms and Impacts, and A Characterization of Pain Among Patients Living With Relapsed/Refractory Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Budget Impact Model to Evaluate the Inclusion of a Pre-Filled Syringe Compared to Vial Application of Denosumab in Patients with Four Cancer Types in Mexico
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada
Mar 10, 2025, 14:00 PM -
Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study
Mar 10, 2025, 14:00 PM -
Estimation of Utilities for Patients with Metastatic Breast Cancer Using Vignette in Japan
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM -
Disparities in Access to COPD Medications in Brazil - Impact of Geography and Socioeconomic Factors on Patient Travel Distances
Mar 10, 2025, 14:00 PM -
Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Assessing Overall Survival and Treatment Impact in Progressive Multifocal Leukoencephalopathy
Mar 10, 2025, 14:00 PM
